Back to search

University of Ioannina

Λογικός σχεδιασμός, σύνθεση και βιολογική αξιολόγηση "έξυπνων μοριακών συσκευών", θεραπευτικών και θεραπογνωστικών μορίων που ανιχνεύουν, στοχεύουν και θεραπεύουν τον καρκίνο

Abstract

dc:description

One of the major health problems faced by developed countries is cancer. The complexity of the disease makes anticancer treatment and especially chemotherapy very difficult as the already existing drugs face significant disadvantages. In addition, the process of discovering new drugs is cost-effective and time-consuming, as a result of which the interest of the scientific community has turned to different approaches. Such is the synthesis of theragnostic molecules that combine the cytotoxic-therapeutic potential among with the diagnostic axis. Their design is based on molecular hybridization with the aim of overcoming the disadvantages of existing drugs as well as attributing new characteristics aiming at selective and effective administration selectively to cancer cells. Molecular hybridization is an idea in the design and development of drugs that relies on the combination of "pharmacophore" moieties of different bioactive compounds to produce a new hybrid compound with new abilities and improved efficacy compared to existing drugs. The design principles are based on the differentiated microenvironment of cancer cells and specifically of certain biomarkers, which can be targeted.Therefore, "smart molecular devices" have been developed that recognize these characteristics of cancer cells that lead to their differentiated environment and to which are responsive, allowing the selective administration of the therapeutic part, when it is observed through alteration of the fluorescent signal, indicatively fluorescent in the near infrared (NIR/SWIR) region, that it has reached the desired target, the cancer cell. The release was carried out after irradiation, at a wavelength and duration not destructive to human tissues (application of EU rules for the maximum permissible exposure (MPE), of a photodegradable ligand. The thepeutic affect was applied through the release of cytotoxic compounds as well as the production of reactive forms of oxygen (ROS) through photodynamic therapy (PDT). These compounds that produce ROS, were based on flavylium salts. These salts were modified accordingly to have absorption in near the NIR region, abilities to detect the cancerous microenvironment and to produce ROS selectively after irradiation. In this way, phototheragnostic compounds were developed that respond to cancer and by irradiation can release ROS through photodynamic therapy to annihilate it. At the same time, using the same core, dyes emitting in the NIR-II/SWIR range were developed, which have many advantages over traditional NIR dyes in terms of in-vivo optical imaging.Accordingly, innovative strategies were used and hybrid compounds based on NIR dyes were developed to design and discover novel “pharmacophores” and modify existing drugs. These compounds target the PI3K-AKT/mTOR signalling pathway, focusing on PI3K inhibition. PI3Ks are kinases that regulate signalling pathways and several cellular processes vital for cancer cells. The inhibitors developed having a combination of "pharmacophore" groups of known kinase inhibitors, both synthetic and natural products, giving in addition to inhibitory activity, fluorescence in the near-infrared region, useful for bioimaging. In particular, these compounds have the ability, after recognition/binding to the desired protein target, to alter their fluorescence signal. Following structure-activity relation studies, compounds were developed where they bind with greater selectivity to the PI3Ka isoform and were evaluated in in-vivo studies against colorectal cancer and triple-negative breast cancer. More specifically, they significantly reduced the size of tumors that were developed in xenografts mice from cancer cells DLD-1 and DLD-1 carrying the E545K PI3K mutation.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chatzigiannis, Christos
  • Χατζηγιάννης, Χρήστος

Subjects

dc:subject × 32

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/53228

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chatzigiannis, Christos; Χατζηγιάννης, Χρήστος. Λογικός σχεδιασμός, σύνθεση και βιολογική αξιολόγηση "έξυπνων μοριακών συσκευών", θεραπευτικών και θεραπογνωστικών μορίων που ανιχνεύουν, στοχεύουν και θεραπεύουν τον καρκίνο. University of Ioannina, 2023. http://hdl.handle.net/10442/hedi/53228